Morgan Stanley's Mike Wilson thinks sectors like housing, commodities, and consumer goods could contain the biggest buying ...

Mike Wilson, Morgan Stanley chief US equity strategist, says "we're in a new bull market." He explains why on "Bloomberg Open ...

Morgan Stanley predicts a bullish market with recovery in earnings revisions, citing AI capex cycles, dollar weakness, & Fed ...

Investors should buy into the selloff in US stocks because of the robust earnings outlook for the coming year, according to ...

Mike Wilson, Morgan Stanley chief U.S. equity strategist, joins 'Squawk Box' to discuss the latest market trends, state of ...

Investing.com -- Morgan Stanley strategist Mike Wilson reiterated his bullish stance on U.S. equities in a note Monday, ...

The new highs keep coming. Futures early Monday showed the S&P 500 on course for its 15th record of 2025. Tariff deals at ...

Earnings are in the midst of a "rolling recovery" that'll boost the S&P 500. AI, fiscal policy, and rate cuts will help the ...

Morgan Stanley backed its bullish stance on U.S. equities on Monday, citing strong earnings momentum, and said it was ...

Figma’s honeymoon on Wall Street just ended in a freefall after mere days. On Monday, the company’s stock collapsed by 23%, ...

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 28, ...

Morgan Stanley (NYSE: MS) maintains a bullish outlook for the next 12 months, leaning toward its S&P 500 bull case of 7200 by mid-2026. Strong earnings momentum, positive operating leverage, and ...